Valuation: Guided Therapeutics Inc

Market Cap 26.55M 23.26M 21.51M 19.77M 37.36M 2.56B 37.93M 257M 101M 1.25B 99.68M 97.5M 4.31B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 29.42M 25.78M 23.84M 21.91M 41.41M 2.84B 42.04M 285M 112M 1.39B 110M 108M 4.78B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 2023-03-05
Chief Tech/Sci/R&D Officer 70 2010-12-01
Director TitleAgeSince
Director/Board Member 76 2006-04-09
Director/Board Member 69 2016-11-09
Director/Board Member 70 2016-11-30
Change 5-day change 1-year change 3-year change Capi.($)
-1.17%-0.16%+26.88%-1.74% 198B
-1.33%+1.03%+5.82%-17.54% 144B
+2.24%-13.18%-31.90%+0.99% 122B
-0.59%-2.23%-57.77%-16.37% 65.44B
-0.85%-7.82%+11.13%-7.23% 49.36B
+0.65%+2.20%-23.34%-30.88% 44.74B
-0.91%-3.00%+14.27%+5.83% 37.13B
-3.10%-5.02%+24.35%+27.66% 36.23B
-0.19%-2.58%-23.00%-8.92% 28.7B
Average -0.70%-2.81%-5.95%-5.35% 80.68B
Weighted average by Cap. -0.73%-2.62%-1.75%-6.34%

Financials

2024 2025
Net sales 7K 6.13K 5.67K 5.21K 9.85K 675K 10K 67.8K 26.56K 330K 26.28K 25.71K 1.14M 767K 672K 622K 571K 1.08M 73.97M 1.1M 7.43M 2.91M 36.19M 2.88M 2.82M 125M
Net income -2.42M -2.12M -1.96M -1.8M -3.4M -233M -3.45M -23.41M -9.17M -114M -9.08M -8.88M -393M -3.2M -2.8M -2.59M -2.38M -4.5M -308M -4.57M -30.95M -12.13M -151M -12M -11.74M -519M
Net Debt 1.77M 1.55M 1.44M 1.32M 2.49M 171M 2.53M 17.15M 6.72M 83.56M 6.65M 6.5M 288M 2.88M 2.52M 2.33M 2.14M 4.05M 277M 4.11M 27.86M 10.91M 136M 10.8M 10.56M 467M
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-